Literature DB >> 24249283

Candida glabrata: a review of its features and resistance.

C F Rodrigues1, S Silva, M Henriques.   

Abstract

Candida species belong to the normal microbiota of the oral cavity and gastrointestinal and vaginal tracts, and are responsible for several clinical manifestations, from mucocutaneous overgrowth to bloodstream infections. Once believed to be non-pathogenic, Candida glabrata was rapidly blamable for many human diseases. Year after year, these pathological circumstances are more recurrent and problematic to treat, especially when patients reveal any level of immunosuppression. These difficulties arise from the capacity of C. glabrata to form biofilms and also from its high resistance to traditional antifungal therapies. Thus, this review intends to present an excerpt of the biology, epidemiology, and pathology of C. glabrata, and detail an approach to its resistance mechanisms based on studies carried out up to the present.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24249283     DOI: 10.1007/s10096-013-2009-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  147 in total

1.  Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata.

Authors:  Samantha C Halliwell; Matthew C A Smith; Philippa Muston; Sara L Holland; Simon V Avery
Journal:  Eukaryot Cell       Date:  2011-12-02

2.  New regulators of biofilm development in Candida glabrata.

Authors:  Marta Riera; Estelle Mogensen; Christophe d'Enfert; Guilhem Janbon
Journal:  Res Microbiol       Date:  2012-03-03       Impact factor: 3.992

3.  Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium.

Authors:  Sónia Silva; Mariana Henriques; Anthony Hayes; Rosário Oliveira; Joana Azeredo; David W Williams
Journal:  J Oral Pathol Med       Date:  2010-12-15       Impact factor: 4.253

4.  In vitro biofilm activity of non-Candida albicans Candida species.

Authors:  Sónia Silva; Mariana Henriques; Rosário Oliveira; David Williams; Joana Azeredo
Journal:  Curr Microbiol       Date:  2010-04-17       Impact factor: 2.188

5.  STB5 is a negative regulator of azole resistance in Candida glabrata.

Authors:  Jason A Noble; Huei-Fung Tsai; Sara D Suffis; Qin Su; Timothy G Myers; John E Bennett
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

6.  Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.

Authors:  George R Thompson; Nathan P Wiederhold; Ana C Vallor; Nyria C Villareal; James S Lewis; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

7.  Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages.

Authors:  Gary M Cox; Thomas S Harrison; Henry C McDade; Carlos P Taborda; Garrett Heinrich; Arturo Casadevall; John R Perfect
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

8.  Disruption of the human pathogenic yeast Candida albicans catalase gene decreases survival in mouse-model infection and elevates susceptibility to higher temperature and to detergents.

Authors:  Yoshiyuki Nakagawa; Toshio Kanbe; Ikuyo Mizuguchi
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

9.  Intestinal resident yeast Candida glabrata requires Cyb2p-mediated lactate assimilation to adapt in mouse intestine.

Authors:  Keigo Ueno; Yasuhiko Matsumoto; Jun Uno; Kaname Sasamoto; Kazuhisa Sekimizu; Yuki Kinjo; Hiroji Chibana
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

10.  The NDR/LATS kinase Cbk1 controls the activity of the transcriptional regulator Bcr1 during biofilm formation in Candida albicans.

Authors:  Pilar Gutiérrez-Escribano; Ute Zeidler; M Belén Suárez; Sophie Bachellier-Bassi; Andrés Clemente-Blanco; Julie Bonhomme; Carlos R Vázquez de Aldana; Christophe d'Enfert; Jaime Correa-Bordes
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

View more
  83 in total

1.  Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.

Authors:  Hedda Luise Koehling; Birgit Willinger; Jan Buer; Peter-Michael Rath; Joerg Steinmann
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Transcriptional responses of Candida glabrata biofilm cells to fluconazole are modulated by the carbon source.

Authors:  Rosana Alves; Stavroula L Kastora; Alexandra Gomes-Gonçalves; Nuno Azevedo; Célia F Rodrigues; Sónia Silva; Liesbeth Demuyser; Patrick Van Dijck; Margarida Casal; Alistair J P Brown; Mariana Henriques; Sandra Paiva
Journal:  NPJ Biofilms Microbiomes       Date:  2020-01-23       Impact factor: 7.290

3.  Functional analysis of selected deletion mutants in Candida glabrata under hypoxia.

Authors:  Payal Gupta; Ramesh Chand Meena; Navin Kumar
Journal:  3 Biotech       Date:  2017-06-29       Impact factor: 2.406

4.  New Aspects of Invasive Growth Regulation Identified by Functional Profiling of MAPK Pathway Targets in Saccharomyces cerevisiae.

Authors:  Matthew D Vandermeulen; Paul J Cullen
Journal:  Genetics       Date:  2020-07-14       Impact factor: 4.562

5.  Diagnostic usefulness of differential time to positivity for catheter-related candidemia.

Authors:  Ki-Ho Park; Mi Suk Lee; Sang-Oh Lee; Sang-Ho Choi; Heungsup Sung; Mi-Na Kim; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

6.  Repeated applications of photodynamic therapy on Candida glabrata biofilms formed in acrylic resin polymerized.

Authors:  Lírian Silva de Figueiredo Freitas; Rodnei Dennis Rossoni; Antonio Olavo Cardoso Jorge; Juliana Campos Junqueira
Journal:  Lasers Med Sci       Date:  2017-01-14       Impact factor: 3.161

7.  Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.

Authors:  Chayanika Biswas; Sharon C-A Chen; Catriona Halliday; Elena Martinez; Rebecca J Rockett; Qinning Wang; Verlaine J Timms; Rajat Dhakal; Rosemarie Sadsad; Karina J Kennedy; Geoffrey Playford; Deborah J Marriott; Monica A Slavin; Tania C Sorrell; Vitali Sintchenko
Journal:  J Vis Exp       Date:  2017-12-28       Impact factor: 1.355

8.  Identification of novel mechanisms involved in generating localized vulvodynia pain.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Christopher J Stodgell; Richard P Phipps
Journal:  Am J Obstet Gynecol       Date:  2015-02-12       Impact factor: 8.661

Review 9.  Isolated Cutaneous Granuloma Caused by Candida glabrata: A Rare Case Report and Literature Review.

Authors:  Yibin Fan; Weili Pan; Guizhen Wang; Youming Huang; Yali Li; Wei Fang; Xiaohua Tao
Journal:  Mycopathologia       Date:  2017-11-22       Impact factor: 2.574

10.  Dectin-1 embraces Candida glabrata.

Authors:  Carlos Del Fresno Sánchez
Journal:  Virulence       Date:  2017-08-24       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.